Chronic knee pain caused by osteoarthritis is one of the leading drivers of physical disability among adults over 45. For millions of patients in the United States, managing knee osteoarthritis often follows a frustrating cycle: temporary relief from corticosteroid injections, physical therapy, daily NSAIDs, and ultimately, the recommendation for invasive total knee replacement surgery (arthroplasty).

In recent years, targeted umbilical cord-derived mesenchymal stem cell (UC-MSC) protocols have emerged as a prominent investigational pathway for joint care, offering patients a non-surgical option to manage intra-articular inflammation and mobility loss.

Understanding Knee Osteoarthritis and Joint Degeneration

Knee osteoarthritis occurs when the protective hyaline cartilage cushioning the ends of your bones gradually wears down. Over time, this erosion leads to bone-on-bone friction, chronic joint inflammation, swelling, stiffness, and severe functional limitations.

While traditional pharmaceuticals focus primarily on masking symptoms, intra-articular cellular therapy aims to address the microenvironment inside the joint capsule.

Key Cellular Mechanisms of UC-MSCs in Joint Care:

• Immunomodulation: Regulating inflammatory cytokines (such as TNF-alpha and IL-1 beta) within the synovial fluid.

• Paracrine Signaling: Releasing trophic factors that stimulate local tissue preservation and microvascular health.

• Reduction of Stiffness: Helping mitigate chronic joint swelling to improve range of motion.

Why Choose Umbilical Cord MSCs (UC-MSCs) Over Autologous Harvest?

Many US clinics utilize autologous stem cells derived from a patient’s own bone marrow (BMAC) or adipose tissue. However, cellular potency and yield decline significantly with age and underlying chronic health conditions.

By contrast, Skyron Medical in Colombia utilizes allogeneic mesenchymal stem cells derived from young, healthy umbilical cord tissue processed by certified laboratories like TRUSTEM BANK.

Advantages of Cord-Derived MSCs for Knee Care:

1. Zero Bone Marrow Aspiration: Eliminates painful donor-site surgical extraction procedures.

2. High Proliferative Capacity: Young cells display robust paracrine and signaling activity.

3. Standardized Dosing: Protocols deliver a precise, verified cell count (e.g., 50 Million viable cells per affected joint).

Precision Delivery: Ultrasound-Guided Intra-Articular Injections

The success of cellular administration depends heavily on placement accuracy. Simply injecting stem cells near a joint does not guarantee proper distribution within the articular space.

At Skyron Medical, all knee osteoarthritis interventions utilize direct ultrasound guidance. This real-time imaging technique allows our medical team to visualize the joint capsule, ensuring that the cellular payload is delivered directly into the intra-articular space under strict aseptic conditions.

Clinical Eligibility and Pre-Travel Requirements

Stem cell therapy for knee osteoarthritis is an investigational supportive intervention and must not be presented as a guaranteed cure or automatic replacement for emergency surgical care. Proper candidate selection is vital for safety and realistic clinical expectations.

Ideal Candidates for Evaluation:

• Adults with documented symptomatic knee osteoarthritis (Grade II to Grade IV).

• Patients who have experienced insufficient relief from conservative care (injections, physical therapy).

• Individuals seeking to delay or avoid invasive knee replacement surgery.

• Patients capable of providing recent standing X-rays or high-resolution Knee MRI reports.

Exclusion Criteria:

• Active septic arthritis or localized skin infections around the knee joint.

• Complete mechanical joint locking or severe structural bone deformity requiring immediate surgical reconstruction.

• Active systemic infection or oncology treatment.

Your Treatment Route at Skyron Medical in Cali, Colombia

Our specialized Knee Osteoarthritis Package ($5,000 USD starting price) provides an all-inclusive 4-day medical route designed for international patients:

1. Pre-Travel MRI & X-Ray Analysis: Complete remote evaluation of your imaging prior to booking travel.

2. On-Site Orthopedic & Joint Assessment: Physical examination in Cali by Dr. Carlos Rojas and our clinical team.

3. Ultrasound-Guided Procedure: Precise intra-articular delivery of 50 Million UC-MSCs per knee.

4. Structured 12-Month Follow-Up: Continuous remote monitoring at Weeks 4, 14, 36, and 52 to track your functional recovery.

Explore Your Options for Non-Surgical Joint Care

If knee pain is restricting your daily activity, walking, or quality of life, explore whether an investigational cellular protocol in Colombia is right for you.

Visit our Knee Osteoarthritis Package Page or submit your recent knee MRI report to schedule a remote file review with Skyron Medical.